These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27116761)

  • 21. Reliability of negative multiparametric MRI of the prostate: can we avoid the biopsy? Not yet!
    Frydenberg M
    BJU Int; 2017 May; 119(5):E9-E10. PubMed ID: 28393492
    [No Abstract]   [Full Text] [Related]  

  • 22. Current role of multiparametric magnetic resonance imaging in the management of prostate cancer.
    Katelaris NC; Bolton DM; Weerakoon M; Toner L; Katelaris PM; Lawrentschuk N
    Korean J Urol; 2015 May; 56(5):337-45. PubMed ID: 25964833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re: Juha Knaapila, Ivan Jambor, Ileana Montoya Perez, et al. Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study. Eur Urol Oncol 2020;3:648-656.
    Jue JS; Alameddine M
    Eur Urol Oncol; 2020 Oct; 3(5):710. PubMed ID: 31882350
    [No Abstract]   [Full Text] [Related]  

  • 24. Simultaneous
    Eiber M; Weirich G; Holzapfel K; Souvatzoglou M; Haller B; Rauscher I; Beer AJ; Wester HJ; Gschwend J; Schwaiger M; Maurer T
    Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Diagnostic Performance of Multiparametric Magnetic Resonance Imaging to Detect Significant Prostate Cancer.
    Thompson JE; van Leeuwen PJ; Moses D; Shnier R; Brenner P; Delprado W; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2016 May; 195(5):1428-1435. PubMed ID: 26529298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric prostate MRI: technical conduct, standardized report and clinical use.
    Manfredi M; Mele F; Garrou D; Walz J; Fütterer JJ; Russo F; Vassallo L; Villers A; Emberton M; Valerio M
    Minerva Urol Nefrol; 2018 Feb; 70(1):9-21. PubMed ID: 28494579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of extracapsular disease with multiparametric magnetic resonance imaging in high risk localized prostate cancer patient.
    Hernández-Sánchez JE; Castillo E; Barbero JM; Lista F; Gonzalez J
    Arch Esp Urol; 2013 Dec; 66(10):956-66. PubMed ID: 24369190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
    Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
    Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric Magnetic Resonance Imaging for Prostate-specific Antigen Recurrence After Radical Prostatectomy: Are We Leaving the "One Treatment Fits All Approach" and Moving Towards Personalized Imaging-guided Treatment?
    Spahn M; Fehr JL
    Eur Urol; 2018 Jun; 73(6):888-889. PubMed ID: 29306515
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of PCA3 and multiparametric MRI's: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL.
    Okcelik S; Soydan H; Ates F; Berber U; Saygin H; Sonmez G; Karademir K
    Int Braz J Urol; 2016; 42(3):449-55. PubMed ID: 27286106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
    Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
    BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
    Franiel T
    Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.
    Hauth E; Hohmuth H; Cozub-Poetica C; Bernand S; Beer M; Jaeger H
    Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
    Radtke JP; Wiesenfarth M; Kesch C; Freitag MT; Alt CD; Celik K; Distler F; Roth W; Wieczorek K; Stock C; Duensing S; Roethke MC; Teber D; Schlemmer HP; Hohenfellner M; Bonekamp D; Hadaschik BA
    Eur Urol; 2017 Dec; 72(6):888-896. PubMed ID: 28400169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
    Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
    Tan N; Margolis DJ; Lu DY; King KG; Huang J; Reiter RE; Raman SS
    AJR Am J Roentgenol; 2015 Jul; 205(1):W87-92. PubMed ID: 26102423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging of prostate cancer.
    Guneyli S; Erdem CZ; Erdem LO
    Clin Imaging; 2016; 40(4):601-9. PubMed ID: 27317204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.